Memorial Sloan Kettering Cancer Center paused a phase 1 trial for a chimeric antigen receptor T-cell therapy to investigate the death of a patient who received the treatment. It was the top story in hematology/oncology last week.
The second top story was about a new study published in JAMA Network Open that found the intake of unprocessed red or processed meat was not associated with an increased risk for colon cancer recurrence or death. Researchers said that more studies are needed to identify and confirm associations between dietary factors and cancer survivorship.
Read these and more top